In this session we discussed key lessons learned for scientists and start-ups to successfully bring to market evidence-based innovative solutions. We will also present non-dilutive funding opportunities and commercialization resources offered through the US small business research programs. A scientist and inventor turned serial entrepreneur will wrap-up the day sharing insights from his previous venture–funded by the NIMH and sold to McKesson–and his current strategy and vision.
--Chair: Dr. Alison Fenney, Executive Director of the Neurotechnology Industry Organization
--Dr. Margaret Grabb, SBIR/STTR Program Director at the National Institute of Mental Health (NIMH)
--Dr. Rex Jakobovits, Founder of Vivalog Technologies and Experiad
Learn more at sharpbrains.com